Anti-TNF therapy has already proven effective in the treatment of RA (48), while IL-1β is also a key proinflammatory cytokine in inflammation-related diseases and cell injury, with disrupted IL-1β signaling accelerating the pathogenesis of inflammatory disease (49). The gene discussed is TNF; the disease is rheumatoid arthritis.